18- Functional Genome Flashcards
define next generation sequencing
a massive parallel modern sequencing technology for high throughput DNA sequencing - includes WES and WGS
enables the rapid sequencing of DNA/RNA base pairs
define whole exome sequencing/WES
type of NGS technique used to capture the sequence of the coding region of the genome - can be used to identify a disease-causing variant
define whole genome sequencing/WGS
used to capture the entire genome which isn’t always necessary - most mutations are in protein-coding regions
what are the clinical advantages of NGS techniques?
looks for variance in patients, gene expression profiles and disease-causing mutations
pushes healthcare towards personalised medicine
describe candidate gene filtering of whole exome sequencing (WES) data
WES can be used to identify a disease-causing variant – less expensive than sequencing an entire genome, majority of mutations are protein-coding
steps to identifying the putative/ disease-causing gene through heuristic candidate gene filtering:
- start with 3 million SNPs = assume the causal variant is coding
- ignore structural variants, other forms of genetic variants, non-coding variants, variants in regulatory elements, promoters, enhancers
- account for indels, insertions, CNVs - 15-20,000 coding SNPs = assume the causal variant is non-synonymous, alters the protein sequence
- synonymous variants are a change in base, not amino acid – exclude
- use software to divide synonymous and non-synonymous variants based on their predicted effects - 7-10,000 coding, non-synonymous SNPs = assume the causal variant has complete penetrance
- disorder is a monogenic Mendelian disease caused by one gene
- not caused by a known gene variant in a publicly available database - 200-500 novel coding non-synonymous SNPs = assume causal variant has complete detectance
- determine mode of inheritance of gene – check for co-segregation of genes within families via sanger sequencing
these steps should produce one putative gene as the answer – further filtering techniques through functional tests can be employed
reasons for doubting this is the putative gene
disease-causing variant may be in a non-coding region, poor coverage of exome
functional tests to support that this is the causative gene variant:
1. in vivo/ vitro models to test gene dysfunction
2. understand molecular mechanisms of gene and how it contributed to the disorder
3. see if encoded gene of interest is present in the patient
4. monitor knockdown/ overexpression of gene in model
5. identify how the mutation is functional, how it affects cell development and protein structure/function
list the in vitro techniques for investigating putative genes
cell culture
gene knockdown
protein localisation
induced pluripotent stem cells
list the in vivo techniques for investigating putative genes
making mutant mice
tissue specific knockout mice through Cre-Lox system
gene knockdown in zebrafish using CRISPR-Cas9
RNA rescue experiments
protein localisation as an in vitro technique
affected protein - can see changes in protein localisation and behaviour based on binding and fluorescence
two methods - antibody staining & GFP tagged gene of interest
antibody staining:
- fragmented peptide injected into host, produces an immune response and antibody production against protein by host
- antibodies isolated, purified and used to bind to protein in cell culture
- host-antibody binds to protein, fluorescently labelled antibody binds to host-antibody
- can show differing levels of binding between mutant and normal protein based on fluorescence
GFP tagged:
- cell containing GFP tagged normal gene of interest transfected with CMV promoter
- cell containing GFP tagged MUTATED gene of interest also transfected with CMV promoter
- transcription in both cells
- GFP fluoresces green under UV light, can compare fluorescence between the two types of cells
in vitro cell culture technique
- cells removed directly from tissues, cell groups disaggregated by enzymes/ mechanically
- cell groups are grown in cultures in favourable artificial conditions. cells have finite divisions – with chemical treatment they’re immortalised = establishes primary culture
- immortalised cells placed in culture and proliferate
- eventually cells are subdivided, sub-cultured and transferred to new dishes with more room and a fresh growth medium – form the subclone/ cell line. these cells proliferate to a limit
- cells with the highest growth capacity dominate cell populations – creates genotypic and phenotypic uniformity within cell population, less variation means less inconsistency in results.
uses of cell culture in vitro studies
metabolic studies
drug screening and vaccines
advantages of cell culture
cheap, grow quickly, easily reproducible with consistent results
easily available commercially
less ethical considerations
define an induced pluripotent stem cell
derived from adult somatic cells
reprogrammed to de-differentiate into embryonic like stem cells
describe the mechanism behind producing an IPSC
non-invasive patient skin biopsy
cells are isolated, cultured and amplified in growth culture
fibroblasts undergo chemical treatment – de-differentiate and become pluripotent stem cells
can be reprogrammed into another cell type the specific genes required for the differentiation process
use of IPSCs
personalised medicine
disease modelling - observing the behaviour of any cell line, IPSCs have the patient’s genetic make up
two methods of genome editing
gene editing - correcting the mutated gene, restoring protein production and function
homology directed repair - repairing double stranded DNA lesions, a type of gene editing
- restores the pathogenic genetic change causing the disorder